Aemetis Stock Gets Increased EPS Forecast from HC Wainwright

Aemetis, Inc (NASDAQ:AMTX – Free Report) – Equities research analysts at HC Wainwright increased their FY2030 earnings per share (EPS) estimates for shares of Aemetis in a research note issued to investors on Friday, November 6th. HC Wainwright analyst A. Dayal now anticipates that the specialty chemicals company will post earnings of $3.46 per share for the year, up from their prior estimate of $3.10. The consensus estimate for Aemetis’ current full-year earnings is ($0.78) per share.

Aemetis (NASDAQ:AMTX – Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The specialty chemicals company reported ($0.02) EPS for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.18. The company had revenue of $88.15 million for the quarter, compared to the consensus estimate of $74.20 million.

Several other brokerages also recently issued reports on AMTX. Wall Street Zen upgraded Aemetis from a “sell” rating to a “hold” rating in a report on Saturday, August 22nd. Weiss Ratings restated a “sell (e+)” rating on shares of Aemetis in a research note on Thursday, October 15th. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $11.88.

Get Our Latest Research Report on Aemetis

Aemetis Stock Down 8.1%

AMTX stock opened at $1.59 on Monday. The firm has a market capitalization of $116.23 million, a PE ratio of -2.84 and a beta of 1.87. Aemetis has a twelve month low of $1.11 and a twelve month high of $3.80. The stock’s 50 day moving average is $1.65 and its 200-day moving average is $1.95.

Institutional Investors Weigh In On Aemetis

A number of institutional investors have recently added to or reduced their stakes in the company. Russell Investments Group Ltd. lifted its position in shares of Aemetis by 458.6% during the 3rd quarter. Russell Investments Group Ltd. now owns 434,404 shares of the specialty chemicals company’s stock worth $773,000 after buying an additional 356,636 shares in the last quarter. Bank of New York Mellon Corp purchased a new position in shares of Aemetis in the 2nd quarter worth approximately $283,000. State of Wyoming bought a new position in shares of Aemetis in the third quarter valued at approximately $226,000. Bank of America Corp DE grew its holdings in shares of Aemetis by 148.3% in the first quarter. Bank of America Corp DE now owns 101,486 shares of the specialty chemicals company’s stock valued at $324,000 after acquiring an additional 60,611 shares in the last quarter. Finally, Renaissance Technologies LLC bought a new position in shares of Aemetis in the first quarter valued at approximately $272,000. 27.02% of the stock is owned by institutional investors.

Key Aemetis News

Here are the key news stories impacting Aemetis this week:

  • Positive Sentiment: Aemetis Biogas received CARB approval for six dairy renewable natural gas pathways. The approval could support progress in developing and monetizing its RNG projects. Aemetis Biogas Receives CARB Approval for Six Dairy RNG Pathways
  • Positive Sentiment: HC Wainwright raised its earnings forecasts across 2026–2029, including lowering its expected 2026 loss and increasing its 2028 and 2029 profit estimates. The revisions indicate a more optimistic outlook, though the nearer-term forecasts still show losses.
  • Neutral Sentiment: A short-interest item claims a large increase but reports total short interest of zero shares. Because those statements conflict, the report offers no clear signal about bearish positioning.
  • Negative Sentiment: A Seeking Alpha analysis argues that Aemetis’ improved quarterly performance has not resolved its financing risk, keeping funding needs and execution as concerns for investors. Aemetis: A Better Quarter Has Not Solved The Financing Risk

About Aemetis

(Get Free Report)

Aemetis, Inc. is a renewable fuels and carbon-reduction company that develops and operates projects designed to produce lower-carbon alternatives to petroleum-based fuels and reduce greenhouse-gas emissions. Its activities include renewable natural gas, ethanol, renewable diesel, and other advanced fuel technologies. The company’s California operations include dairy-based renewable natural gas projects that capture methane from dairy waste and convert it into pipeline-quality fuel. Aemetis also operates an ethanol production facility in Keyes, California, which produces ethanol and related co-products from agricultural feedstocks.

Read More

Earnings History and Estimates for Aemetis (NASDAQ:AMTX)

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.